Neuland Laboratories [NEULANDLAB] vs Caplin Point [CAPLIPOINT] Detailed Stock Comparison

Neuland Laboratories

NSE
Loading...

Caplin Point

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Neuland Laboratories wins in 6 metrics, Caplin Point wins in 14 metrics, with 0 ties. Caplin Point appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricNeuland LaboratoriesCaplin PointBetter
P/E Ratio (TTM)103.8628.90Caplin Point
Price-to-Book Ratio12.005.86Caplin Point
Debt-to-Equity Ratio10.310.17Caplin Point
PEG Ratio-1.211.25Neuland Laboratories
EV/EBITDA79.4322.86Caplin Point
Profit Margin (TTM)13.24%28.42%Caplin Point
Operating Margin (TTM)4.88%31.65%Caplin Point
EBITDA Margin (TTM)4.88%31.65%Caplin Point
Return on Equity17.06%18.58%Caplin Point
Return on Assets (TTM)11.93%16.71%Caplin Point
Free Cash Flow (TTM)$1.11B$2.41BCaplin Point
Dividend Yield0.08%0.26%Caplin Point
1-Year Return15.30%14.22%Neuland Laboratories
Price-to-Sales Ratio (TTM)13.768.17Caplin Point
Enterprise Value$184.68B$154.69BNeuland Laboratories
EV/Revenue Ratio13.897.78Caplin Point
Gross Profit Margin (TTM)47.77%61.73%Caplin Point
Revenue per Share (TTM)$1,037$262Neuland Laboratories
Earnings per Share (Diluted)$137.36$73.99Neuland Laboratories
Beta (Stock Volatility)0.010.03Neuland Laboratories
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Neuland Laboratories vs Caplin Point Stock Performance Analysis

Loading Price Chart...

Neuland Laboratories
Caplin Point
Neuland Laboratories Stock Overview | Caplin Point Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Neuland Laboratories-0.11%5.14%8.55%13.52%26.58%0.97%
Caplin Point1.27%3.60%4.56%7.45%15.53%-12.28%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Neuland Laboratories15.30%1,040.23%1,108.69%1,904.58%17,615.72%16,792.56%
Caplin Point14.22%198.05%271.15%619.50%5,473.85%5,473.85%

News Based Sentiment: Neuland Laboratories vs Caplin Point

Neuland Laboratories

News based Sentiment: MIXED

Neuland Laboratories experienced a challenging quarter but is actively investing in future growth through capacity expansion and industry engagement. Analyst forecasts are positive, but current financial performance remains a concern, creating a mixed investment narrative.

View Neuland Laboratories News Sentiment Analysis

Caplin Point

News based Sentiment: POSITIVE

Caplin Point Laboratories delivered a strong first quarter and secured key USFDA approvals for its products, signaling continued growth and strategic progress. Positive analyst ratings and a commitment to shareholder returns further strengthen the investment case, making this a significant month for the company.

View Caplin Point News Sentiment Analysis

Performance & Financial Health Analysis: Neuland Laboratories vs Caplin Point

MetricNEULANDLABCAPLIPOINT
Market Information
Market Cap i₹186.31B₹165.85B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i35,05383,803
90 Day Avg. Volume i57,445125,742
Last Close₹14,433.00₹2,203.90
52 Week Range₹10,190.70 - ₹18,100.00₹1,599.00 - ₹2,641.00
% from 52W High-20.26%-16.55%
All-Time High₹18,100.00 (Dec 02, 2024)₹2,641.00 (Dec 23, 2024)
% from All-Time High-20.26%-16.55%
Growth Metrics
Quarterly Revenue Growth-0.33%0.11%
Quarterly Earnings Growth-0.86%0.23%
Financial Health
Profit Margin (TTM) i0.13%0.28%
Operating Margin (TTM) i0.05%0.32%
Return on Equity (TTM) i0.17%0.19%
Debt to Equity (MRQ) i10.310.17
Cash & Liquidity
Book Value per Share (MRQ)₹1,188.48₹365.07
Cash per Share (MRQ)₹186.76₹118.75
Operating Cash Flow (TTM) i₹3.44B₹5.31B
Levered Free Cash Flow (TTM) i₹2.60B₹5.36B
Dividends
Last 12-Month Dividend Yield i0.08%0.26%
Last 12-Month Dividend i₹12.00₹5.50

Valuation & Enterprise Metrics Analysis: Neuland Laboratories vs Caplin Point

MetricNEULANDLABCAPLIPOINT
Price Ratios
P/E Ratio (TTM) i103.8628.90
Forward P/E i38.8721.28
PEG Ratio i-1.211.25
Price to Sales (TTM) i13.768.17
Price to Book (MRQ) i12.005.86
Market Capitalization
Market Capitalization i₹186.31B₹165.85B
Enterprise Value i₹184.68B₹154.69B
Enterprise Value Metrics
Enterprise to Revenue i13.897.78
Enterprise to EBITDA i79.4322.86
Risk & Other Metrics
Beta i0.010.03
Book Value per Share (MRQ) i₹1,188.48₹365.07

Financial Statements Comparison: Neuland Laboratories vs Caplin Point

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)NEULANDLABCAPLIPOINT
Revenue/Sales i₹2.93B₹5.02B
Cost of Goods Sold i₹1.53B₹2.01B
Gross Profit i₹1.40B₹3.01B
Research & Development iN/AN/A
Operating Income (EBIT) i₹142.99M₹1.51B
EBITDA i₹423.45M₹1.94B
Pre-Tax Income i₹175.70M₹1.77B
Income Tax i₹36.70M₹313.90M
Net Income (Profit) i₹139.00M₹1.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)NEULANDLABCAPLIPOINT
Cash & Equivalents i₹1.32B₹1.99B
Total Current Assets i₹11.39B₹21.34B
Total Current Liabilities i₹4.66B₹3.06B
Long-Term Debt i₹1.09B₹29.10M
Total Shareholders Equity i₹15.25B₹28.86B
Retained Earnings i₹9.95BN/A
Property, Plant & Equipment i₹6.74B₹5.35B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)NEULANDLABCAPLIPOINT
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNEULANDLABCAPLIPOINT
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i35,05383,803
Average Daily Volume (90 Day) i57,445125,742
Shares Outstanding i12.83M76.01M
Float Shares i7.19M19.26M
% Held by Insiders i0.38%0.73%
% Held by Institutions i0.25%0.05%

Dividend Analysis & Yield Comparison: Neuland Laboratories vs Caplin Point

MetricNEULANDLABCAPLIPOINT
Last 12-Month Dividend i₹12.00₹5.50
Last 12-Month Dividend Yield i0.08%0.26%
3-Year Avg Annual Dividend i₹12.00₹4.83
3-Year Avg Dividend Yield i0.20%0.20%
3-Year Total Dividends i₹36.00₹14.50
Ex-Dividend DateJul 18, 2025May 30, 2025